Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluation of a Carbon Fiber Device for Spinal Surgery

Official title: Carbofix Pedicle Screw System: Randomized Clinical Trial to Evaluate the Clinical and Radiographic Outcomes of the Use of a Carbon Fiber Device Compared to Titanium Devices in Patients Undergoing Spinal Arthrodesis for Degenerative Spinal Diseases

Run by Istituto Ortopedico Rizzoli · NCT06209684 · Data updated 2026-11-12

This study is testing a new carbon fiber device for spinal surgery to see if it works better than traditional titanium screws for patients with degenerative spinal diseases.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment118 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Drugs / interventionsradiation
Locations1 site (Bologna)
StatusRecruiting
StartedApril 29, 2022
Main results expectedSeptember 29, 2026
Study endsApril 29, 2027
Registry record updatedMay 22, 2026
Trial IDNCT06209684 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older suffering from degenerative spinal pathology or spondylolisthesis requiring instrumented stabilization.

Probably not a fit

Patients with metabolic bone diseases, neoplastic diseases, or those who are pregnant will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the clinical and radiographic outcomes of using a carbon fiber pedicle screw system compared to traditional titanium devices in patients undergoing spinal fusion for degenerative spinal diseases. It aims to assess the effectiveness of the carbon device, which has previously shown promise in cancer patients due to its low interference with radiation and superior imaging capabilities. A total of 118 patients requiring 1 or 2 levels of lumbar or lumbosacral fusion will be included in the evaluation. The study seeks to fill a gap in the literature regarding the use of carbon fiber in lumbar degenerative pathologies.

Why it matters

Potential benefit: If successful, this study could provide a safer and more effective option for spinal stabilization in patients with degenerative spinal diseases.

How similar studies have gone: While previous studies have shown the effectiveness of carbon devices in cancer patients, this approach in degenerative spinal conditions is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients suffering from degenerative spinal pathology or spondylolisthesis who require instrumented stabilization on 1-2 levels;
* Age greater than or equal to 18 years;
* Ability to understand and sign the informed consent to the study and to follow the required follow-ups.

Exclusion Criteria:

* Metabolic bone disease.
* History of Paget's disease or other osteodystrophies, whether acquired or congenital, including renal osteodystrophy, hyperthyroidism, hypothyroidism, Ehlers-Danlos syndrome, osteogenesis imperfecta, achondroplasia.
* Neoplastic disease.
* History of mental disorder or current psychiatric treatment.
* Pregnancy.
* Immunodeficiency diseases.
* Infectious bone disease (discitis, osteomyelitis)
* Treatment with drugs that can interfere with bone metabolism
* Inability to understand and sign the informed consent to the study and to follow the required follow-up visits.
* Alcohol and/or drug abuse
* Obesity
* Metal allergy
* Participation in other studies on drugs or devices (within 30 days)

Where it's running

  • Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.